LI-TING HOLIAN-YU LINYang, Yao-HsuYao-HsuYangCHO-KAI WUJYH-MING JIMMY JUANGYI-CHIH WANGCHIA-TI TSAILING-PING LAIHWANG, JUEY-JENJUEY-JENHWANGFU-TIEN CHIANGJIUNN-LEE LINPAU-CHUNG CHEN2020-11-252020-11-252015-12-1501675273https://scholars.lib.ntu.edu.tw/handle/123456789/522102The objective is to assess the effectiveness of statin use to prevent atrial fibrillation (AF) in dialysis patients.enAtrial fibrillation; Dialysis; Propensity score; Statins[SDGs]SDG3atorvastatin; fluindostatin; hydroxymethylglutaryl coenzyme A reductase inhibitor; simvastatin; dipeptidyl carboxypeptidase inhibitor; hydroxymethylglutaryl coenzyme A reductase inhibitor; adult; age distribution; aged; Article; atrial fibrillation; brain ischemia; cardiovascular risk; comorbidity; controlled study; coronary artery disease; diabetes mellitus; dose response; drug efficacy; end stage renal disease; female; heart failure; heart protection; hemodialysis; human; hyperlipidemia; hypertension; major clinical study; male; new-onset atrial fibrillation; outcome assessment; peripheral occlusive artery disease; priority journal; risk assessment; risk reduction; sex difference; Taiwan; adolescent; atrial fibrillation; incidence; Kidney Failure, Chronic; middle aged; risk factor; statistics and numerical data; treatment outcome; very elderly; Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Taiwan; Treatment Outcomejournal article10.1016/j.ijcard.2015.01.04026322603WOS:000366144200150